Zachary Tracer

President-elect Donald Trump outlined some pieces of his healthcare program, largely following ideas he laid out during his campaign, from a repeal of Obamacare, his predecessor’s signature health law, to language indicating opposition to abortion.

Individuals signing up for plans this year are facing not only rising premiums, but also fewer options to choose from after several big insurers pulled out from some of the markets created under the Affordable Care Act.

Company is the first major U.S. health insurer to post third-quarter results, and investors will use the results as a barometer for the rest of the industry.

A growing number of people in the Affordable Care Act are finding out their health insurance plans will disappear from the program next year, forcing them to find new coverage even as options shrink and prices rise.

Letters and e-mails between the two companies may become evidence in the Justice Department’s lawsuit seeking to halt the $48 billion.

Insurer will reevaluate its approach to the Affordable Care Act after suffering significant losses under the U.S. program and will pull out of Dallas and New Jersey markets next year.

Startup backed by Silicon Valley investors, posted losses in New York, Texas and California in the first half of the year, the latest example of insurers both large and small losing money in new markets created by President Barack Obama’s health care overhaul.

Later this year, residents of Pinal County, Ariz., who go shopping for health insurance under the ACA will face a peculiar dilemma — they’ll have to buy a product that may not exist.

Aetna will stop selling individual ACA plans next year in 11 of the 15 states where it had been participating in the program, joining other major insurers that have pulled out of the government-run markets in the face of mounting losses.

Chief Executive Officer David Cordani faces a tough task: persuading investors and lawyers that the health insurer is committed to a troubled $48 billion takeover, while also talking up its prospects as an independent company.

The Empire State's insurance regulator has “significant concerns’’ about proposed $48 billion acquisition will hold a hearing to address them before deciding whether to approve the deal.

Hours after the U.S. government sued to block two major health insurance mergers, one deal appears headed for the courthouse while the other could be headed to the graveyard.

U.S. antitrust enforcers roundly rejected a pair of proposed deals that would consolidate the nation’s five biggest health insurers into three.

UnitedHealth Group Inc., the largest U.S. health insurer, reported second-quarter profit that beat analysts’ estimates, driven by growth at its Optum technology and consulting unit.

The Obama administration’s top health official highlighted the importance of competition to insurance markets, as the Justice Department is poised to decide on two massive deals among four of the health-plan industry’s biggest players.

The insurance commissioner in the country’s most populous state calls on the government to block Anthem Inc.’s $48 billion takeover of rival health insurer Cigna Corp., saying the deal would limit competition in the state’s health-insurance market.

Citing increased risk and low profits, the health insurer says it will exit a ‘handful’ of state exchanges.

UnitedHealth Group Inc.’s OptumRx unit struck an agreement to ease customers’ access to drugs through Walgreens Boots Alliance Inc.’s drugstores, a move to help the business compete with rival pharmacy benefit managers.

Aetna Inc. is quitting the health insurance industry’s main lobbying group, dealing a second blow to the organization just months after the exit of UnitedHealth Group Inc.

A set of delays on Affordable Care Act-related taxes in the new federal spending bill will give corporate earnings a modest boost but are unlikely to undo the law or produce significant changes in the healthcare industry.